vxco-100
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 11, 2023 (NCT05870839)
Timeline
No events for the selected filters.
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
immunity, active - sars-cov-2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05938075 | Phase 1 | Aug 4, 2023 | Medical Research Council, South Africa, Perinatal HIV Research Unit, Baragwanath |
| NCT05870839 | Phase 1 | May 11, 2023 | Emory University, University of Maryland, University of Rochester |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Medical Research Council, South Africa | Government | 1 | 0 | 1 | 2023 |
| Perinatal HIV Research Unit, Baragwanath | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2023 |
5 organizations
Page 1 / 1